GlassScriptPhysician profile
John J Connolly
NPI 1962450312
$718.76
in general payments reported to CMS, 2019-2025
19 companies · $60.65 in 2025
The $60.65 reported for 2025 was less than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $72.18 · 2021: $131 · 2023: $140 · 2025: $60.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $130.64 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.41 | 2019 | |
| Novo Nordisk INC | $67.85 | 2019-2023 | Wegovy, Saxenda |
| Abbvie INC. | $66.97 | 2023-2025 | Vraylar |
| Lilly USA, LLC | $60.37 | 2019-2023 | Zepbound, Jardiance, Trulicity |
| Pfizer INC. | $49.05 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $48.09 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $40.34 | 2019-2023 | Farxiga |
| Neurelis, INC. | $23.65 | 2023 | Valtoco |
| Mylan Specialty L.P. | $23.21 | 2019 | |
| Becton, Dickinson and Company | $22.78 | 2025 | Hemosphere |
| Amarin Pharma, INC. | $15.25 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.12 | 2020 | |
| Merck Sharp & Dohme LLC | $13.16 | 2019 | |
| Glaxosmithkline, LLC. | $13.01 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $12.37 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.90 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.83 | 2019 | |
| Boston Scientific Corporation | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Connolly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.